Sera Prognostics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sera Prognostics, Inc. on November 8, 2021. The Company is an emerging growth company incorporated in Delaware, with its Class A Common Stock trading on The Nasdaq Stock Market LLC under the symbol "SERA". The report primarily addresses corporate governance changes regarding the Board of Directors.
Key Financial Metrics
The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The only financial figures disclosed relate to director compensation:
- Stock Option Grant: A non-qualified stock option with a Grant Date fair value of $240,000.
- Annual Cash Retainer: $35,000, prorated for the portion of the year served.
Material Changes
The material change reported is the appointment of Evguenia (Zhenya) Lindgardt as a Class III Director, effective November 8, 2021. Her term will expire at the Company's 2024 annual meeting of stockholders. No other material changes to operations or financial status are reported in this document.
Outlook, Risks, and Unusual Items
Management Commentary: The Board believes Ms. Lindgardt is qualified based on her extensive experience in technology and healthcare, including roles at Uber Technologies Inc., The Boston Consulting Group, and The Commons Project Foundation.
Compensation Structure: The stock option vests in 36 substantially equal monthly installments, contingent on continued service. An indemnification agreement has been executed to protect Ms. Lindgardt for expenses incurred in her service as a director.
Risks and Contingencies: The filing states there are no transactions in which Ms. Lindgardt has a material interest requiring disclosure under Item 404(a) of Regulation S-K, and no family relations with existing directors or officers.
Key Facts for Investor Verification
- Verify the vesting schedule and exercise price of the $240,000 stock option granted to the new director.
- Confirm the total number of outstanding shares and the impact of this grant on dilution.
- Review the Company's Non-Employee Director Compensation Policy for consistency with peer companies.
- Monitor future announcements regarding Ms. Lindgardt's committee assignments, which were not determined at the time of filing.